Mariana Oncology’s CEO talks about radiopharmaceuticals and last week’s $175M Series B financing

blonca9
Sep 11, 2023
1 min read

Simon Read discusses the use cases for radiopharmaceuticals, why Mariana has chosen small cell lung cancer for its first indication, and investing in CMC early.

Recent Posts

See All

On its 10-year anniversary, Arcus Biosciences is taking its 4th molecule into pivotal studies. Co-Founder & CEO Terry Rosen talks HIF-2⍺, TIGIT, and CD73

Siren Biotechnology is using an online platform to raise up to $5 million from the public in a "community round" - it might be a new avenue of funding for biotech companies

Theravance Biopharma has a key pivotal trial readout scheduled for late '25 / early '26 in symptomatic neurogenic orthostatic hypotension (nOH) in patients with multiple system atrophy (MSA)

Mariana Oncology’s CEO talks about radiopharmaceuticals and last week’s $175M Series B financing

Recent Posts

Join the BiotechTV mailing list

Follow BiotechTV

Sponsors

Sponsor Spotlight